Oncology Institute Inc.
(TOI)
undefined
undefined%
At close: undefined
0.22
-3.49%
After-hours Dec 13, 2024, 06:13 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Revenue | 324.24M | 252.48M | 203.00M | 187.51M | 155.41M | 113.16M |
Cost of Revenue | 264.67M | 200.39M | 162.16M | 150.64M | 125.46M | 86.88M |
Gross Profit | 59.57M | 52.09M | 40.85M | 36.88M | 29.94M | 26.28M |
Operating Income | -77.02M | -72.01M | -45.86M | -8.20M | -2.63M | 4.79M |
Interest Income | - | 4.08M | 320.00K | 254.15K | 3.38K | - |
Pretax Income | -83.10M | 1.90M | -11.60M | -14.81M | -2.64M | 4.86M |
Net Income | -83.07M | 1.66M | -10.93M | -14.32M | -4.02M | 3.95M |
Selling & General & Admin | 113.85M | 119.69M | 83.36M | 41.90M | 29.64M | 20.39M |
Research & Development | - | - | - | - | - | - |
Other Expenses | 22.74M | 4.41M | 3.34M | 3.18M | 2.94M | 1.10M |
Operating Expenses | 136.59M | 124.10M | 86.71M | 45.07M | 32.59M | 21.49M |
Interest Expense | 6.78M | 4.08M | 320.00K | 347.06K | 3.38K | 1.59K |
Selling & Marketing Expenses | - | - | - | 41.59M | - | - |
Cost & Expenses | 401.26M | 324.49M | 248.86M | 195.71M | 158.05M | 108.37M |
Income Tax | -36.00K | 247.00K | -671.00K | -492.82K | 1.38M | 912.75K |
Shares Outstanding (Basic) | 73.75M | 72.79M | 66.23M | 59.12M | 64.45M | 28.75M |
Shares Outstanding (Diluted) | 73.75M | 80.61M | 66.23M | 59.12M | 64.45M | 28.75M |
EPS (Basic) | -0.92 | 0.02 | -0.16 | -0.24 | -0.06 | 0.14 |
EPS (Diluted) | -0.92 | 0.02 | -0.16 | -0.24 | -0.06 | 0.14 |
EBITDA | -70.45M | 8.40M | -7.94M | -11.29M | 307.11K | 9.08M |
Depreciation & Amortization | 5.87M | 4.41M | 3.34M | 3.18M | 2.94M | 1.10M |